Skip to content

Welcome to Discover Pharma! Today is : November 12, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Drug Discovery & Development

  • Drug Discovery & Development

    Lubrizol hits clinical milestone with novel solubility-enhancing excipient

    Apisolex polymer excipient formulation enters Phase 1 trials, supporting delivery [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    RBQMLive returns in 2025 with agenda on regulation, ROI and AI in clinical trials

    CluePoints releases full speaker lineup for free virtual event focused [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development

    Novadip’s autologous cell therapy NVD003 receives RMAT designation for rare pediatric bone disorder

    FDA recognises regenerative approach for congenital pseudarthrosis of the tibia [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development

    EC approves ADCETRIS-based BrECADD regimen for newly diagnosed advanced Hodgkin lymphoma

    Takeda’s antibody-drug conjugate gains second frontline indication following positive Phase [...]

    May 5, 2026
  • Drug Discovery & Development,Manufacturing & Supply Chain

    As BIO International 2025 closes – Discover Pharma captures voices shaping pharma’s next chapter

    As the global biopharma industry gathered at BIO International in [...]

    May 5, 2026
  • Drug Delivery & Formulation,Drug Discovery & Development

    Bio-Rad expands antibody and SpyCatcher ranges to support drug development and bioanalysis

    Bio-Rad Laboratories has introduced five new recombinant monoclonal anti-idiotypic antibodies [...]

    May 5, 2026
  • Drug Delivery & Formulation,Drug Discovery & Development

    UK poised to lead in functional genomics, BIA says

    The BioIndustry Association (BIA) has released a new explainer highlighting [...]

    May 5, 2026
  • Advanced Therapies,Drug Discovery & Development

    Enhanced Genomics appoints biotech veteran Dietrich Stephan as chair to drive next-gen target discovery

    Enhanced Genomics has appointed leading biotechnology entrepreneur Dietrich Stephan as [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Digital & Data,Drug Discovery & Development

    Sofinnova Partners and NVIDIA join forces to boost European AI in life sciences

    Sofinnova Partners has announced a new collaboration with NVIDIA to [...]

    May 5, 2026
  • Drug Discovery & Development

    Elkedonia raises EUR 11.25 million to develop new treatment for depression and other neuropsychiatric disorders

    New approach targets Elk1 to restore neuroplasticity without sedation or [...]

    May 5, 2026
Previous707172Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Aravind and Alcon launch global retina surgery training centre in India
    Categories: Medical devices, Research & Development
  • Atsena receives EMA orphan designation for two inherited retinal disease gene therapies
    Categories: Advanced Therapies, Clinical & Regulatory, Genomics and sequencing, Pharmaceuticals and therapeutics, Research & Development
  • IOTA founder recognised for global impact on ovarian tumour diagnosis
    Categories: Clinical & Regulatory, Medical devices, Pharmaceuticals and therapeutics, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top